IGF2BP1 and ovarian cancer: Through pathway expression verification, we confirmed that the FTH1 m6A methylation regulatory pathway (CACNA1G-AS1/IGF2BP1) was obviously increased in ovarian cancer samples, and its expression was closely related to tumor malignancy.